Nobel Laureate at Pittcon
Nobel Laureate, Sir Harold (Harry) Kroto, will present the Wallace H. Coulter Plenary Lecture at Pittcon 2013.
Nobel Laureate, Sir Harold (Harry) Kroto, will present the Wallace H. Coulter Plenary Lecture at Pittcon 2013. His talk will be entitled “Exameter Objects to Nanometer Ones and Back Again”. The plenary lecture will be part of the opening session for the event, which will be held in the Pennsylvania Convention Centre, Philadelphia, Pennsylvania, USA, 17–21 March 2013.
Sir Harold is currently Francis Eppes professor of chemistry at Florida State University, Tallahassee, Florida, USA, investigating nanoscience and cluster chemistry. He was knighted for his contributions to chemistry in 1996 and later in the same year his laboratory experiments involving the simulation of chemical reactions in the atmospheres of red giant stars uncovered the existence of C60 — also know as Buckminsterfullerene — the third well-characterized allotrope of carbon.
Kroto, together with Robert Curl and Richard Smalley, won the 1996 Nobel Prize in Chemistry for this ground-breaking work. He has won numerous other awards including the Copley Medal and Faraday Lectureship of the Royal Society.
For more information about the event visit www.pittcon.org
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
